×
The CCR2 inflammatory pathway is a target for improving severe disease and pulmonary inflammation in experimental COVID-19
Kazungu Y., Hegde S., Sharma P., Marriott A., Steven A., Reine J., Dagley J., Mack M., Stewart J., Turner JD.
DOI
10.1101/2025.03.28.645941
Type
Preprint
Publication Date
2025-03-31T00:00:00+00:00